News
FAT jabs can treat a liver disease affecting one in five people, a trial found. Semaglutide cut inflammation in two thirds of ...
1h
Health and Me on MSNWeight Loss Pills Could Help Tackle Obesity In Poorer Countries, Experts SayA new generation of oral weight loss medications could transform the fight against obesity and diabetes in low- and ...
11h
Pharmaceutical Technology on MSNMagazine: The GLP-1 shortage is over. What’s next for compounders?The future for GLP-1RA compounders, steps pharma can take in light of rising trial costs, funding ultra-rare therapies, and ...
Over the past several decades, epidemiologic studies have documented declines in sperm count and quality. During the same ...
The NBA Hall of Famer joined forces with the telehealth platform to restart his weight loss journey and raise awareness about ...
A doctor has warned of the potential dangers of a 'game changing' diabetes drug which could rival the likes of Ozempic. The ...
Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo ...
On Friday, Mad Money host Jim Cramer took a close look at what he called one of the most important stretches of the earnings ...
Compounded tirzepatide contains the same active ingredient as Mounjaro, but its dosage and some ingredients may differ from ...
Medications taken for weight loss are starting to impact wedding planning — and perhaps nothing more than the dress fitting.
Mounjaro (tirzepatide) is quickly becoming a breakthrough option for people managing type 2 diabetes and those seeking ...
A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results